Integrating adherence to highly active antiretroviral therapy into children's daily lives: a qualitative study

Naïma Hammami1, Christiana Nöstlinger, Tom Hoerée

  • 1Nutrition and Child Health Unit, Institute of Tropical Medicine, Antwerp, Belgium.

Pediatrics
|November 3, 2004
PubMed

Insights

Caregivers

Area of Science:

  • Pediatric Infectious Diseases
  • HIV/AIDS Management
  • Treatment Adherence Research

Background:

  • Pediatric highly active antiretroviral therapy (HAART) adherence is crucial for managing HIV/AIDS.
  • Understanding caregiver influences on pediatric HAART adherence is essential for effective treatment outcomes.

Purpose of the Study:

  • To explore factors influencing adherence to highly active antiretroviral therapy (HAART) in children.
  • To gain a deeper understanding of caregiver roles in pediatric HAART adherence.

Main Methods:

  • Qualitative study involving interviews with 11 primary caregivers of children on HAART.
  • Adherence assessed via caregiver self-report and laboratory results.
  • Content analysis of interviews to identify themes influencing adherence.

Main Results:

  • Adherent caregivers demonstrated stronger internalization of medical information and personal cost-benefit analyses.
  • Enhanced problem-solving skills were associated with better adherence.
  • Knowledge, motivation, and capacities evolved dynamically with HIV coping stages.

Conclusions:

  • HIV coping mechanisms and adherence are interrelated; disease acceptance fosters motivation and adherence.
  • Problem-solving skills are key to sustained adherence.
  • Tailored interventions addressing individual coping strategies are needed to improve pediatric HAART adherence.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...